ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC

Clinical trial NCT06426511 · RECRUITING

Trial details

NCT number: NCT06426511
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer, Nonsmall Cell

Start date: 2024-12-01
Primary completion: 2026-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.